ENTITY
Venus MedTech

Venus MedTech (2500 HK)

109
Analysis
Health CareChina
Venus MedTech (HangZhou) Inc. develops and sells cardiovascular devices. The Company offers products including aorta, compression loading and conveying systems, and pulmonary artery. Venus MedTech (HangZhou) markets its products throughout China.
more
Refresh
16 Jun 2020 19:19

Hygeia Healthcare IPO (Part I): A Better Healthcare

Hygeia Healthcare is an oncology healthcare service provider in China who operates hospitals as well as provides third-party radiotherapy services...

Share
16 Jun 2020 00:25

Kangji Medical IPO: Valuation Insights

Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...

Logo
353 Views
Share
bearishVenus MedTech
11 Jun 2020 16:58

Venus Medtech Lock-Up Expiry: Could Face Selling Pressure

Venus Medtech is a dominant player in the heart valve replacement (TAVR) market in China and was listed in Hong Kong on December 10th. Since...

Logo
408 Views
Share
11 Jun 2020 11:27

Kangji Medical (康基医疗) Pre-IPO: COVID-19 Impacts and Thoughts on Valuation

Kangji Medical is a domestic leader in minimally invasive surgery devices. It has three main product types, trocars, polymer ligation clips, and...

Logo
504 Views
Share
bullishPeijia Medical
14 May 2020 13:27

Peijia Medical IPO: Trading Debut Equals First-Day Pop?

Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijia will commence trading on Friday, 15 May. At...

Logo
302 Views
Share
x